Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Corbin J. Eule

TitleAsst Professor
InstitutionUniversity of Colorado Denver - Anschutz Medical Campus
DepartmentSOM-MED

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Jones MK, Nicklawsky A, Shortt J, Pattee J, Kennerley V, Eule CJ, Candelario N, O'Donnell PH, Flaig TW. Pharmacogenomics of chemotherapy induced peripheral neuropathy using an electronic health record-derived definition: a genome-wide association study. Support Care Cancer. 2025 Apr 08; 33(5):362. PMID: 40198382.
      View in: PubMed
    2. Callihan EB, Kuna EM, Eule CJ, Kessler ER, Flaig TW. Practice patterns and outcomes of conventional versus split-dose cisplatin in neoadjuvant ddMVAC in bladder cancer. Bladder Cancer. 2025 Jan-Mar; 11(1):23523735241310388. PMID: 40034243.
      View in: PubMed
    3. Wiesen BM, Flaig TW, Gershman B, Konety B, Warren A, Kuna EM, Robin T, Kessler ER, Eule CJ, Breyer BN, Achua J, Kim SP. Racial Disparities in Clinical Trial Enrollment Among Patients Diagnosed With Prostate Cancer: A Population-Based Cohort of Oncology Practices. Adv Urol. 2024; 2024:8871425. PMID: 39735345.
      View in: PubMed
    4. Eule CJ, Warren A, Molina Kuna E, Robin TP, Gershman B, Kim SP, Flaig TW. Clinical characteristics and treatment of patients with small cell prostate cancer: analysis of a real-world cohort from an oncology database. Prostate Cancer Prostatic Dis. 2025 Jun; 28(2):444-450. PMID: 39572637.
      View in: PubMed
    5. Eule CJ, Candelario N, Nath SK, Robin TP. Time to Next Systemic Therapy After Stereotactic Body Radiation Therapy for Oligoprogressive Metastatic Castrate-Resistant Prostate Cancer. Adv Radiat Oncol. 2024 Dec; 9(12):101655. PMID: 39620140.
      View in: PubMed
    6. Eule CJ, Kuna EM, Robin TP, Gershman B, Flaig TW, Kim SP. Treatment Intensification in Metastatic Hormone-Sensitive Prostate Cancer: An Analysis of Real-World Practice Patterns from the CancerLinQ Database. Urol Oncol. 2024 12; 42(12):447.e17-447.e24. PMID: 39191549.
      View in: PubMed
    7. Eule CJ, Hu J, Hedges D, Jani A, Pshak T, Manley BJ, Sanchez A, Dreicer R, Myint ZW, Zakharia Y, Lam ET. Clinical and Genomic Features of Patients with Renal Cell Carcinoma and Advanced Chronic Kidney Disease: Analysis of a Multi-Institutional Database. Cancers (Basel). 2024 May 18; 16(10). PMID: 38791999.
      View in: PubMed
    8. Eule CJ, Warren A, Molina Kuna E, Callihan EB, Kim SP, Flaig TW. Neoadjuvant Cisplatin-based Chemotherapy in Nonmetastatic Muscle-invasive Bladder Cancer: A Systematic Review and Pooled Meta-analysis to Determine the Preferred Regimen. Urology. 2024 06; 188:118-124. PMID: 38685388.
      View in: PubMed
    9. Kessler ER, Callihan E, Hu J, Eule C, Srivastava G, Kemme DJ, Iruku P, Rana V, Moore J, Schuster SR, Amirault M, Flaig TW, Lam ET. A Phase I/II Clinical Trial of Pembrolizumab and Cabozantinib in Metastatic Renal Cell Carcinoma. Cancer Res Commun. 2023 06; 3(6):1004-1012. PMID: 37377613.
      View in: PubMed
    10. Eule CJ, Hu J, Al-Saad S, Collier K, Boland P, Lewis AR, McKay RR, Narayan V, Bosse D, Mortazavi A, Rose TL, Costello BA, Bryce AH, Lam ET. Outcomes of Second-Line Therapies in Patients With Metastatic de Novo and Treatment-Emergent Neuroendocrine Prostate Cancer: A Multi-Institutional Study. Clin Genitourin Cancer. 2023 08; 21(4):483-490. PMID: 37193610.
      View in: PubMed
    11. Eule CJ, Flaig TW, Wong K, Graf R, Lam ET. Effectiveness and durability of benefit of mTOR inhibitors in a real-world cohort of patients with metastatic prostate cancer and PI3K pathway alterations. Prostate Cancer Prostatic Dis. 2023 03; 26(1):188-193. PMID: 36402814.
      View in: PubMed
    12. Eule C, Arora N, Li HC, Sadeghi N. Presentation and management of primary mediastinal large B-cell lymphoma: a retrospective cohort analysis. Acta Oncol. 2020 Jul; 59(7):786-788. PMID: 32233823.
      View in: PubMed
    13. Arora N, Eule C, Gupta A, Li HC, Sadeghi N. Clinicopathologic features, management, and outcomes of plasmablastic lymphoma: A 10-year experience. Am J Hematol. 2019 05; 94(5):E127-E129. PMID: 30734351.
      View in: PubMed
    14. Eule C, Gupta A, Nagalla S. The Direct Antiglobulin Test for Evaluating Anemia. JAMA. 2018 Dec 25; 320(24):2593-2594. PMID: 30508030.
      View in: PubMed
    15. Eule C, Bhulani N, Paulk E, Rhodes R, Beg MS. Characteristics and impact of the most-cited palliative oncology studies from 1995 to 2016. BMC Cancer. 2018 Dec 22; 18(1):1281. PMID: 30577766.
      View in: PubMed
    16. Keshvani N, Gupta A, Eule C, Sadeghi N. Sacral bone cyst treatment resulting in paraplegia. BMJ Case Rep. 2018 Jan 18; 2018. PMID: 29351944.
      View in: PubMed
    Eule's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description

    Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)